Gene,Target,Drug_ID,Drug_name,Approval_status,SMILES
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D01ZAQ,Capivasertib,Approved,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0I4TH,GDC-0068,Phase 3,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0I6VU,Enzastaurin,Phase 3,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D02NXM,GSK2110183,Phase 2,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D07SYZ,RX-0201,Phase 2,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0S5WP,Trametinib + 2141795,Phase 2,failed
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0X7CV,PTX-200,Phase 2,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D01TBJ,CMX-2043,Phase 2,CC(C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CCCCC1CCSS1
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D07DWF,ARQ 092,Phase 2,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0YB3W,CI-1033,Phase 2,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D09CCZ,Triciribine prodrug,Phase 1/2,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D02QWY,BMS-754807,Phase 1,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0L8PZ,ARQ 751,Phase 1,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D06HYF,M2698,Phase 1,C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D07QBF,PMID28460551-Compound-6,Patented,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0O1AV,Squalestatin 1,Terminated,CCC(C)CC(C)C=CC(=O)OC1C(C2(OC(C(C1(O2)C(=O)O)(C(=O)O)O)C(=O)O)CCC(=C)C(C(C)CC3=CC=CC=C3)OC(=O)C)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D07MQF,MYRIOCIN,Investigative,CCCCCCC(=O)CCCCCCC=CCC(C(C(CO)(C(=O)O)N)O)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D09DGE,LD-101,Investigative,C1=C(C(=O)C2=C(N=CN=C2N1C3C(C(C(O3)CO)O)O)N)C(=O)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0CM6T,A-674563,Investigative,CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CC=CC=C4)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0F8HX,Lactoquinomycin,Investigative,CC1C(C(CC(O1)C2=C(C3=C(C=C2)C(=O)C4=C(C3=O)C(OC5C4OC(=O)C5)C)O)N(C)C)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0N7CY,VLI-27,Investigative,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0OX1T,A-443654,Investigative,CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0PX5F,NU-1001-41,Investigative,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0RZ1H,"4,5,6-trihydroxy-3-methylphthalide",Investigative,CC1C2=C(C(=C(C=C2C(=O)O1)O)O)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0V1ES,ALM-301,Investigative,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0L5AB,BX-517,Investigative,CC(=C1C2=C(C=CC(=C2)NC(=O)N)NC1=O)C3=CC=CN3
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0MH9X,"Inositol 1,3,4,5-Tetrakisphosphate",Investigative,C1(C(C(C(C(C1OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O)OP(=O)(O)O)O
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D00ATA,(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one,Investigative,C1=CC=C2C(=C1)C(=CC3=CC=CN3)C(=O)N2
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D05APZ,Akt inhibitor VIII,Investigative,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0I1FJ,SB-747651A,Investigative,CCN1C2=C(C=NC=C2CNC3CCNCC3)N=C1C4=NON=C4N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0L2WP,PMID20005102C1,Investigative,CC1=C2C=C(C=CC2=NN1)C3=C(N=CC(=C3)OCC(CC4=CNC5=CC=CC=C54)N)C6=COC=C6
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0GB4V,STAUROSPORINONE,Investigative,
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0M5FF,Ro31-8220,Investigative,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0M4SY,BMS-536924,Investigative,CC1=CC(=CC2=C1N=C(N2)C3=C(C=CNC3=O)NCC(C4=CC(=CC=C4)Cl)O)N5CCOCC5
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0N6ES,KN-62,Investigative,CN(C(CC1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC3=C2C=CN=C3)C(=O)N4CCN(CC4)C5=CC=CC=C5)S(=O)(=O)C6=CC=CC7=C6C=CN=C7
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0B9BU,CI-1040,Investigative,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0O1YH,"4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole",Investigative,C1(=C(C2=NNN=C2C(=C1Br)Br)Br)Br
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0A5RM,"4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol",Investigative,C1=CC(=O)C=CC1=NNC2=C(NN=C2N)N
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0TO6S,Bisindolylmaleimide-I,Investigative,CN(C)CCCN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54
AKT1,RAC-alpha serine/threonine-protein kinase (AKT1),D0L8HO,RO-316233,Investigative,C1=CC=C2C(=C1)C(=CN2)C3=C(C(=O)NC3=O)C4=CNC5=CC=CC=C54
AKT2,RAC-beta serine/threonine-protein kinase (AKT2),D0M9QJ,PHT-427,Investigative,CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)NC2=NN=CS2
AKT2,RAC-beta serine/threonine-protein kinase (AKT2),D05APZ,Akt inhibitor VIII,Investigative,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8
AKT2,RAC-beta serine/threonine-protein kinase (AKT2),D0L2WP,PMID20005102C1,Investigative,CC1=C2C=C(C=CC2=NN1)C3=C(N=CC(=C3)OCC(CC4=CNC5=CC=CC=C54)N)C6=COC=C6
AURKB,Aurora kinase B (AURKB),D05PZB,AT9283,Phase 3,C1CC1NC(=O)NC2=C(NN=C2)C3=NC4=C(N3)C=C(C=C4)CN5CCOCC5
AURKB,Aurora kinase B (AURKB),D0A1AQ,Rosiglitazone + metformin,Phase 3,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O
AURKB,Aurora kinase B (AURKB),D02XNW,VX-680,Phase 2,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C
AURKB,Aurora kinase B (AURKB),D08HOM,ABT-348,Phase 2,C1=CC(=CC(=C1)F)NC(=O)NC2=CC=C(C=C2)C3=CSC4=C3C(=NC=C4C5=CN(N=C5)CCO)N
AURKB,Aurora kinase B (AURKB),D02RJY,PHA-739358,Phase 2,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC
AURKB,Aurora kinase B (AURKB),D08HFW,TAK-901,Phase 1,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C
AURKB,Aurora kinase B (AURKB),D09KRU,BI-831266,Phase 1,
AURKB,Aurora kinase B (AURKB),D0P5IZ,BI-811283,Phase 1,
AURKB,Aurora kinase B (AURKB),D0Q7RE,AZD-1152-HQPA,Phase 1,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO
AURKB,Aurora kinase B (AURKB),D08DCP,BI-847325,Phase 1,CCNC(=O)C#CC1=CC2=C(C=C1)C(=C(N2)O)C(=NC3=CC=C(C=C3)CN(C)C)C4=CC=CC=C4
AURKB,Aurora kinase B (AURKB),D0E5XA,R763,Phase 1,CC1=C(C=CC(=C1)NC2=NC=C(C(=N2)NC3C4CC(C3C(=O)N)C=C4)F)N5CCN(CC5)C
AURKB,Aurora kinase B (AURKB),D0IQ0Z,GSK1070916,Phase 1,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C
AURKB,Aurora kinase B (AURKB),D0J6AB,MK-5108,Phase 1,C1CC(CCC1OC2=C(C(=CC=C2)Cl)F)(CC3=NC(=CC=C3)NC4=NC=CS4)C(=O)O
AURKB,Aurora kinase B (AURKB),D0P0HU,GSK1070916A,Phase 1,
AURKB,Aurora kinase B (AURKB),D05LKZ,HPP-607,Phase 1,
AURKB,Aurora kinase B (AURKB),D0CY1B,CYC116,Phase 1,CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4
AURKB,Aurora kinase B (AURKB),D0EJ3B,AMG 900,Phase 1,CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N
AURKB,Aurora kinase B (AURKB),D0OA5G,SNS-314,Phase 1,C1=CC(=CC(=C1)Cl)NC(=O)NC2=NC=C(S2)CCNC3=NC=NC4=C3SC=C4
AURKB,Aurora kinase B (AURKB),D0H7AC,PF-03814735,Discontinued in Phase 1,CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F
AURKB,Aurora kinase B (AURKB),D14NDZ,Deguelin,Investigative,CC1(C=CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC)C
AURKB,Aurora B messenger RNA (AURKB mRNA),D02RJY,PHA-739358,Phase 2,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC
AURKB,Aurora B messenger RNA (AURKB mRNA),D05WSM,HESPERADIN,Investigative,CCS(=O)(=O)NC1=CC2=C(C=C1)NC(=C2C(=NC3=CC=C(C=C3)CN4CCCCC4)C5=CC=CC=C5)O
AURKB,Aurora B messenger RNA (AURKB mRNA),D07PVS,ISIS 173848,Investigative,
AURKB,Aurora B messenger RNA (AURKB mRNA),D0K1JI,ISIS 173813,Investigative,
AURKB,Aurora B messenger RNA (AURKB mRNA),D0PI2A,ISIS 173831,Investigative,
AURKB,Aurora B messenger RNA (AURKB mRNA),D0Y5UO,ISIS 173840,Investigative,
AURKB,Aurora B messenger RNA (AURKB mRNA),D04MYT,"4-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine",Investigative,C1=CNC2=NC=CC(=C21)C3=CNN=C3
AURKB,Aurora B messenger RNA (AURKB mRNA),D06LJL,PMID16451062C46,Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=NC=C(S3)CC(=O)NC4=CC(=CC=C4)F)OCCCN5CCC(CC5)CO
AURKB,Aurora B messenger RNA (AURKB mRNA),D0I1IK,7-fluoroindirubin-3-acetoxime,Investigative,CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=C3C=CC=C4F)O
AURKB,Aurora B messenger RNA (AURKB mRNA),D0K6VW,7-iodoindirubin-3-oxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)I)NO
AURKB,Aurora B messenger RNA (AURKB mRNA),D0K8YI,7-chloroindirubin-3-oxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)Cl)NO
AURKB,Aurora B messenger RNA (AURKB mRNA),D0L1GF,7-bromoindirubin-3-oxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)C3C4=C(C(=CC=C4)Br)NC3=O)N=O
AURKB,Aurora B messenger RNA (AURKB mRNA),D0U8VY,quinazoline deriv. 1,Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OC
AURKB,Aurora B messenger RNA (AURKB mRNA),D00TKJ,7-fluoroindirubin-3-oxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)C3=C4C=CC=C(C4=NC3=O)F)NO
AURKB,Aurora B messenger RNA (AURKB mRNA),D01TDV,PMID21742770C1,Investigative,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=C3)C=NN4C5=CC=C(C=C5)OC)OC
AURKB,Aurora B messenger RNA (AURKB mRNA),D06AGN,Indirubin-3-acetoxime,Investigative,CC(=O)ON=C1C2=CC=CC=C2N=C1C3=C(NC4=CC=CC=C43)O
AURKB,Aurora B messenger RNA (AURKB mRNA),D0A7FQ,CGP-57380,Investigative,C1=CC(=CC=C1NC2=C3C(=NC=NC3=NN2)N)F
AURKB,Aurora B messenger RNA (AURKB mRNA),D0ME9B,PMID20855207C25,Investigative,CC1CN(CC(O1)C)C(C)C2=NSC(=C2)NC3=NC(=CN4C3=NC=C4C5=CNN=C5)C
AURKB,Aurora B messenger RNA (AURKB mRNA),D0V6LP,Indirubin-3-methoxime,Investigative,CON=C1C2=CC=CC=C2N=C1C3=C(NC4=CC=CC=C43)O
AURKB,Aurora B messenger RNA (AURKB mRNA),D06OAH,6-bromoindirubin-3-oxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)C3=C(NC4=C3C=CC(=C4)Br)O)N=O
AURKB,Aurora B messenger RNA (AURKB mRNA),D0CE3R,SU 6656,Investigative,CN(C)S(=O)(=O)C1=CC2=C(C=C1)NC(=O)C2=CC3=CC4=C(N3)CCCC4
AURKB,Aurora B messenger RNA (AURKB mRNA),D0Y0ES,Indirubin-3'-monoxime,Investigative,C1=CC=C2C(=C1)C(=C(N2)O)C3=C(C4=CC=CC=C4N3)N=O
CTSK,Cathepsin K (CTSK),D0J6AU,Odanacatib,Phase 3,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F
CTSK,Cathepsin K (CTSK),D07BIK,VEL-0230,Phase 1,CC(C)CC(COCC(C)C)NC(=O)C1C(O1)C(=O)[O-].[Na+]
CTSK,Cathepsin K (CTSK),D08KIB,SAR-114137,Phase 1,CCC(C(=O)C1=NOC(=N1)C2=CC=CC=C2)NC(=O)C(CC(=O)N3CCOCC3)CS(=O)(=O)CC(C)C
CTSK,Cathepsin K (CTSK),D00KGL,PMID27998201-Compound-8,Patented,
CTSK,Cathepsin K (CTSK),D0BR6D,PMID27998201-Compound-10,Patented,CC(C)CC(C1=CC=CC(=C1)C2=CC=C(C=C2)C3=CC=CC=C3)C(=O)N(C)N(C)C#N
CTSK,Cathepsin K (CTSK),D0MR9V,PMID27998201-Compound-15,Patented,
CTSK,Cathepsin K (CTSK),D0QM0D,Oxotetrahydro-2-H-furo[3.2-b]pyrrol-4(5-H)-yl derivative 1,Patented,C1CCC(CC1)C(C(=O)N2CC(C3C2C(=O)CO3)Cl)NC(=O)C4=CC=CC(=C4)C5=CNN=C5
CTSK,Cathepsin K (CTSK),D04VGR,PMID27998201-Compound-9,Patented,CC(C)CC(C(=O)N(C)N(C)C#N)NC(=O)C1=CC=CC(=C1)C2=CC=C(C=C2)C3=CC=CC=C3
CTSK,Cathepsin K (CTSK),D06LLT,PMID25399719-Compound-17,Patented,
CTSK,Cathepsin K (CTSK),D05OIU,PMID27998201-Compound-5,Patented,CC#CC(C(OC1=CC=C(C=C1)SC)(F)F)NC(CSCC2CC2)C(=O)NC3(CC3)C#N
CTSK,Cathepsin K (CTSK),D06XCD,PMID27998201-Compound-12,Patented,
CTSK,Cathepsin K (CTSK),D00ZUU,ONO-5334,Discontinued in Phase 2,CC1CSC(=NNC(=O)C(=O)C(C2CCOCC2)NC(=O)C3CCCCCC3)N1C
CTSK,Cathepsin K (CTSK),D01LNG,Balicatib,Discontinued in Phase 2,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N
CTSK,Cathepsin K (CTSK),D0T5PH,Relacatib,Discontinued in Phase 2,CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3
CTSK,Cathepsin K (CTSK),D0J5FU,MIV-701,Discontinued in Phase 1,
CTSK,Cathepsin K (CTSK),D0FJ3P,GW-2592X,Preclinical,
CTSK,Cathepsin K (CTSK),D0Z0PR,L-006235-1,Preclinical,CN1CCN(CC1)C2=NC(=CS2)C3=CC=C(C=C3)C(=O)NC4(CCCCC4)C(=O)NCC#N
CTSK,Cathepsin K (CTSK),D00FGA,Pyrrolidine-1-carbonitrile,Investigative,C1CCN(C1)C#N
CTSK,Cathepsin K (CTSK),D00QIA,(S)-tert-butyl 4-methyl-1-oxopentan-2-ylcarbamate,Investigative,CC(C)CC(C=O)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D00TRY,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,Investigative,CC(C)(C)OC(=O)NC(C=O)C1CCCCC1
CTSK,Cathepsin K (CTSK),D02QOT,3-Amino-5-Phenylpentane,Investigative,C1=CC=C(C=C1)CCC(CCS(=O)(=O)C2=CC=CC=C2)N
CTSK,Cathepsin K (CTSK),D02TNR,N-(1-((cyanomethyl)carbamoyl)cyclohexyl)benzamide,Investigative,C1CCC(CC1)(C(=O)NCC#N)NC(=O)C2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D04HBH,AM-3701,Investigative,
CTSK,Cathepsin K (CTSK),D04QHB,2-cyclohexylamino-pyrimidine-4-carbonitrile,Investigative,C1CCC(CC1)NC2=NC=CC(=N2)C#N
CTSK,Cathepsin K (CTSK),D06AZJ,4-cyclohexylamino-pyrimidine-2-carbonitrile,Investigative,C1CCC(CC1)NC2=NC(=NC=C2)C#N
CTSK,Cathepsin K (CTSK),D0A8PI,Boc-Agly-Val-Agly-OEt,Investigative,CCOC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D0B2FE,4-phenyl-6-propylpyrimidine-2-carbonitrile,Investigative,CCCC1=CC(=NC(=N1)C#N)C2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D0FC7L,2-cyclohexylamino-pyridine-2-carbonitrile,Investigative,C1CCC(CC1)NC2=CC=CC(=N2)C#N
CTSK,Cathepsin K (CTSK),D0H8CC,Tert-butyl (2S)-1-cyanopyrrolidine-2-carboxylate,Investigative,CC(C)(C)OC(=O)C1CCCN1C#N
CTSK,Cathepsin K (CTSK),D0MM4X,MIV-710,Investigative,
CTSK,Cathepsin K (CTSK),D0P5BY,N-(cyanomethyl)cyclohex-1-ene-1-carboxamide,Investigative,C1CCC(=CC1)C(=O)NCC#N
CTSK,Cathepsin K (CTSK),D0V1UZ,BF/PC-21,Investigative,
CTSK,Cathepsin K (CTSK),D0W0BK,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,Investigative,CC(C)(C)OC(=O)NN(C)C#N
CTSK,Cathepsin K (CTSK),D0Y5LX,4-cyclohexyl-6-propylpyrimidine-2-carbonitrile,Investigative,CCCC1=CC(=NC(=N1)C#N)C2CCCCC2
CTSK,Cathepsin K (CTSK),D00NVC,Z-Ala-Leu-Nal-Agly-Ile-Val-OMe,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC2=CC=CC=C21)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC3=CC=CC=C3
CTSK,Cathepsin K (CTSK),D01BIZ,Z-Arg-Leu-Val-Agly-Trp-Val-Ala-NH2,Investigative,CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3
CTSK,Cathepsin K (CTSK),D01JGB,4-cyclooctyl-6-propylpyrimidine-2-carbonitrile,Investigative,CCCC1=CC(=NC(=N1)C#N)C2CCCCCCC2
CTSK,Cathepsin K (CTSK),D01TFO,Z-Ala-Leu-lle-Agly-Ile-Val-OMe,Investigative,CCC(C)C(C(=O)NNC(=O)NC(C(C)CC)C(=O)NC(C(C)C)C(=O)OC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D03ETT,Z-Ala-Leu-His-Agly-Ile-Val-OMe,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CN=CN1)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D03FJH,Z-Arg-Leu-Val-Agly-Ile-Val-Trp-NH2,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)OC)NC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3
CTSK,Cathepsin K (CTSK),D03VHO,Z-Ala-Leu-Tyr(Me)-Agly-Ile-Val-OMe,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=C(C=C1)OC)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D04BGT,4-propyl-6-m-tolylpyrimidine-2-carbonitrile,Investigative,CCCC1=CC(=NC(=N1)C#N)C2=CC=CC(=C2)C
CTSK,Cathepsin K (CTSK),D05WZF,"P2,P3 Ketoamide derivative",Investigative,CN(C)S(=O)(=O)NCCCCC(C(=O)C(=O)NCC1=CN=CC=C1)NC(=O)OCC2(CCC2)CC3=CC=C(C=C3)F
CTSK,Cathepsin K (CTSK),D06QJT,Z-leu-Val-Agly-Val-OBzl,Investigative,CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C(C)C)C(=O)OCC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D07JLV,Z-Ala-Leu-lle-Agly-Ile-Val-NHBzl,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)NCC1=CC=CC=C1)NC(=O)NNC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D07RDV,Z-Ala-Leu-Phe-Agly-Ile-Val-OMe,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)OCC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D0A7ER,N-(tert-butoxycarbonyl)-norvalyl-glycine-nitrile,Investigative,CCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D0G2QG,PMID16290936C1b,Investigative,CCCCC(C=O)NC(=O)OC(C)CC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D0H8TE,Z-Arg-Leu-Val-Agly-Ala-Gly-NH2,Investigative,CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C)C(=O)NCC(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D0N7BP,Z-Arg-Leu-Val-Agly-Val-Ala-NH2,Investigative,CC(C)CC(C(=O)NC(C(C)C)C(=O)NNC(=O)NC(C(C)C)C(=O)NC(C)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D0Q4YY,Z-Arg-Leu-Val-Agly-Ileu-Val-OMe,Investigative,CCC(C)C(C(=O)NC(C(C)C)C(=O)OC)NC(=O)NNC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)OCC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D0T7QF,(S)-tert-butyl 1-oxohexan-2-ylcarbamate,Investigative,CCCCC(C=O)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D0U4TY,4-cycloheptyl-6-propylpyrimidine-2-carbonitrile,Investigative,CCCC1=CC(=NC(=N1)C#N)C2CCCCCC2
CTSK,Cathepsin K (CTSK),D01YNC,N-(tert-butoxycarbonyl)-isoleucyl-glycine-nitrile,Investigative,CCC(C)C(C(=O)NCC#N)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D06VIP,N-(tert-butoxycarbonyl)-valyl-glycine-nitrile,Investigative,CC(C)C(C(=O)NCC#N)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D07FLB,N-(tert-butoxycarbonyl)-norleucyl-glycine-nitrile,Investigative,CCCCC(C(=O)NCC#N)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D07RSA,N-(4-phenylbenzoyl)-phenylalanyl-glycine-nitrile,Investigative,C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=C(C=C2)C3=CC=CC=C3
CTSK,Cathepsin K (CTSK),D09AHN,N-(tert-butoxycarbonyl)-leucyl-glycine-nitrile,Investigative,CC(C)CC(C(=O)NCC#N)NC(=O)OC(C)(C)C
CTSK,Cathepsin K (CTSK),D0A8OV,N-acetyl-phenylalanyl-glycine-nitrile,Investigative,CC(=O)NC(CC1=CC=CC=C1)C(=O)NCC#N
CTSK,Cathepsin K (CTSK),D0G8OD,N-(benzyloxycarbonyl)-leucyl-glycine-nitrile,Investigative,CC(C)CC(C(=O)NCC#N)NC(=O)OCC1=CC=CC=C1
CTSK,Cathepsin K (CTSK),D0JN8Q,N-benzoyl-phenylalanyl-glycine-nitrile,Investigative,C1=CC=C(C=C1)CC(C(=O)NCC#N)NC(=O)C2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D0U0XG,N-(tert-butoxycarbonyl)-methionyl-glycine-nitrile,Investigative,CC(C)(C)OC(=O)NC(CCSC)C(=O)NCC#N
CTSK,Cathepsin K (CTSK),D0VE0F,(S)-1-benzylcyclopentyl 1-oxohexan-2-ylcarbamate,Investigative,CCCCC(C=O)NC(=O)OC1(CCCC1)CC2=CC=CC=C2
CTSK,Cathepsin K (CTSK),D0D0LD,L-873724,Investigative,CC(C)CC(C(=O)NCC#N)NC(C1=CC=C(C=C1)C2=CC=C(C=C2)S(=O)(=O)C)C(F)(F)F
CTSK,Cathepsin K (CTSK),D0L9VP,GNF-PF-5434,Investigative,CC(C)CC(C(=O)NC(CCC1=CC=CC=C1)C=CS(=O)(=O)C2=CC=CC=C2)NC(=O)N3CCOCC3
EGFR,Epidermal growth factor receptor (EGFR),D03WPP,Necitumumab,Approved,
EGFR,Epidermal growth factor receptor (EGFR),D05GGP,HEGF,Approved,
EGFR,Epidermal growth factor receptor (EGFR),D07POC,Erlotinib,Approved,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
EGFR,Epidermal growth factor receptor (EGFR),D09XZB,Gefitinib,Approved,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
EGFR,Epidermal growth factor receptor (EGFR),D0HU9H,Panitumumab,Approved,
EGFR,Epidermal growth factor receptor (EGFR),D0N5OV,Cetuximab,Approved,
EGFR,Epidermal growth factor receptor (EGFR),D05UFG,BIBW 2992,Approved,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4
EGFR,Epidermal growth factor receptor (EGFR),D07YDE,Nitroglycerin,Approved,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
EGFR,Epidermal growth factor receptor (EGFR),D08TPS,Epidermal growth factor,Approved,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)NC(C(C)C)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC7=CN=CN7)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)CNC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C(CS)NC(=O)CNC(=O)C1CCCN1C(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)N
EGFR,Epidermal growth factor receptor (EGFR),D0O8GK,Osimertinib,Approved,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
EGFR,Epidermal growth factor receptor (EGFR),D0U1ZV,NERATINIB MALEATE,Approved,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C.C(=CC(=O)O)C(=O)O
EGFR,Epidermal growth factor receptor (EGFR),DQ5X1Z,Amivantamab,Approved,
EGFR,Epidermal growth factor receptor (EGFR),D03MNN,SKI-758,Approved,CN1CCN(CC1)CC2=CC(=CO2)C3=C(C=C4C(=C3)N=CC(=C4NC5=CC(=C(C=C5Cl)Cl)OC)C#N)OC
EGFR,Epidermal growth factor receptor (EGFR),D06XXH,Dacomitinib,Approved,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4
EGFR,Epidermal growth factor receptor (EGFR),D08CDI,Lapatinib,Approved,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
EGFR,Epidermal growth factor receptor (EGFR),D0F0ZE,Merimepodib,Approved,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4
EGFR,Epidermal growth factor receptor (EGFR),D0G6QF,Vandetanib,Approved,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC
EGFR,Epidermal growth factor receptor (EGFR),D0W5HK,Sorafenib,Approved,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
EGFR,Epidermal growth factor receptor (EGFR),D06WRJ,Icotinib hydrochloride,Registered,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4.Cl
EGFR,Epidermal growth factor receptor (EGFR),D05FRP,Rindopepimut,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),D0CR8H,SYM-004,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),D0FJ1W,DE-766,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),D0K7FY,EGF816,Phase 3,CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2C4CCCCN(C4)C(=O)C=CCN(C)C)C(=CC=C3)Cl
EGFR,Epidermal growth factor receptor (EGFR),D0M4AV,CO-1686,Phase 3,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC
EGFR,Epidermal growth factor receptor (EGFR),D0R4PW,Zalutumumab,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),DDH8L6,Almonertinib,Phase 3,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC
EGFR,Epidermal growth factor receptor (EGFR),DWK96T,ASP1929,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),DXZ31K,A140,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),D09BKY,Bevacizumab + Erlotinib,Phase 3,
EGFR,Epidermal growth factor receptor (EGFR),D0Q9CY,HKI-272,Phase 3,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C
EGFR,Epidermal growth factor receptor (EGFR),D0F3KC,Indium-111,Phase 2/3,
EGFR,Epidermal growth factor receptor (EGFR),D00NYJ,Varlitinib,Phase 2/3,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl
EGFR,Epidermal growth factor receptor (EGFR),D02BYZ,ASP8273,Phase 2,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC5CCN(C5)C(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D06XIT,ABT-414,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0A6CC,Depatuxizumab,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0BZ7V,Matuzumab,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0C3LL,HER1-VSSP vaccine,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0FN4T,RM-1929,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0K9MC,CetuGEX,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0P9RG,ABX-EGF,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0S3PO,Pelitinib,Phase 2,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C
EGFR,Epidermal growth factor receptor (EGFR),D00YER,HM-78136B,Phase 2,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D03UKJ,Pazopanib + Tyverb/Tykerb,Phase 2,failed
EGFR,Epidermal growth factor receptor (EGFR),D09BZJ,MEHD-7945A,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0T5JS,TT-100,Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0U4FF,BMS-599626,Phase 2,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F
EGFR,Epidermal growth factor receptor (EGFR),DUW81M,Tarloxotinib,Phase 2,CN1C=NC(=C1C[N+](C)(C)CC=CC(=O)NC2=NC=C3C(=C2)C(=NC=N3)NC4=CC(=C(C=C4)Cl)Br)[N+](=O)[O-]
EGFR,Epidermal growth factor receptor (EGFR),D0P6DJ,VATALANIB,Phase 2,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4
EGFR,Epidermal growth factor receptor (EGFR),D0R6UV,BMS-690514,Phase 2,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N
EGFR,Epidermal growth factor receptor (EGFR),D0YB3W,CI-1033,Phase 2,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
EGFR,Epidermal growth factor receptor (EGFR),D04DHZ,CART-EGFR,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D05ETC,SN-32793,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D0G1ZU,EGFR CART,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D0S8BG,EMD 55900,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),DC1GH7,TAK-186,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),DF0PR6,ZN-e4,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),DWQ6J1,EMB-01,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D0B4OK,Sym015,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D9FJ5V,BDTX-189,Phase 1/2,C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)OCCN5CCOCC5
EGFR,Epidermal growth factor receptor (EGFR),DK8QG3,AFM24,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D0FF2G,Sym013,Phase 1/2,
EGFR,Epidermal growth factor receptor (EGFR),D0V4XY,S-222611,Phase 1b,
EGFR,Epidermal growth factor receptor (EGFR),D00KML,SYN004,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D00RMC,BIBX-1382,Phase 1,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl
EGFR,Epidermal growth factor receptor (EGFR),D04HSH,IMGN289,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D04OLK,AST-1306,Phase 1,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl
EGFR,Epidermal growth factor receptor (EGFR),D05LMC,AMG 595,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0E7RC,HER-2/HER-1 vaccine,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0I7ZH,EGFR806-specific CAR T cell,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0JS0W,PF-05230907,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0N3PC,MR1-1,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0T0SE,Anti-EGFR CAR T,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0X7BN,AP32788,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D68RMI,CLN-081,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D01IJM,LY3164530,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D01NAP,MM-151,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D08JAN,Cipatinib,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0JW2O,Anti-HER3/EGFR DAF,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0U7XJ,BCA101,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0Z4RC,CUDC-101,Phase 1,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO
EGFR,Epidermal growth factor receptor (EGFR),D6JM8Z,SI-B001,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D73FNL,CX-904,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),DN47VK,AZD9592,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),DR4ND6,D2C7,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),DV8I4Q,MCLA-158,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0U3XL,JNJ-26483327,Phase 1,
EGFR,Epidermal growth factor receptor (EGFR),D0Z2PC,"Pyrrolo[2,3-d]pyrimidine derivative 24",Patented,COCCOC1=CC=C(C=C1)NC2=NC3=C(C=CN3)C(=N2)OC4=CC=CC(=C4)NC(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D07GFF,PKI166,Discontinued in Phase 2,CC(C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O
EGFR,Epidermal growth factor receptor (EGFR),D0E2CQ,RG7160,Discontinued in Phase 2,
EGFR,Epidermal growth factor receptor (EGFR),D0Q7HO,PD-153035,Discontinued in Phase 1,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OC
EGFR,Epidermal growth factor receptor (EGFR),D02RZL,AZD4769,Discontinued in Phase 1,C1=CC=C(C=C1)CCCC(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)SCC(=O)O
EGFR,Epidermal growth factor receptor (EGFR),D0A9OV,TAK165,Discontinued in Phase 1,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F
EGFR,Epidermal growth factor receptor (EGFR),D0V2FZ,111In-hEGF,Preclinical,
EGFR,Epidermal growth factor receptor (EGFR),D0TI4U,EGFR/IGFR tandem adnectin,Preclinical,
EGFR,Epidermal growth factor receptor (EGFR),D02GFZ,Heparin-EGF-like factor,Terminated,
EGFR,Epidermal growth factor receptor (EGFR),D03QTP,CGP-52411,Terminated,C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4
EGFR,Epidermal growth factor receptor (EGFR),D0HO1S,CGP-53353,Terminated,C1=CC(=CC=C1NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)F)F
EGFR,Epidermal growth factor receptor (EGFR),D0Y1YX,AZD-9935,Terminated,
EGFR,Epidermal growth factor receptor (EGFR),D00TJF,"N4-(3-chlorophenyl)quinazoline-4,6-diamine",Investigative,C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)N
EGFR,Epidermal growth factor receptor (EGFR),D00VZA,"2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile",Investigative,C1=CC=C(C=C1)C(=O)C(=CC2=CC(=C(C=C2)O)O)C#N
EGFR,Epidermal growth factor receptor (EGFR),D00WZG,"6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)C#CCOC3=CC=CC=C3)OC
EGFR,Epidermal growth factor receptor (EGFR),D01NTW,"2-cyano-3-(3,4-dihydroxyphenyl)acrylamide",Investigative,C1=CC(=C(C=C1C=C(C#N)C(=O)N)O)O
EGFR,Epidermal growth factor receptor (EGFR),D01SQP,HM-61713B,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D01WDI,Benzyl-quinazolin-4-yl-amine,Investigative,C1=CC=C(C=C1)CNC2=NC=NC3=CC=CC=C32.Cl
EGFR,Epidermal growth factor receptor (EGFR),D01WXV,"6,7-diethoxy-4-styrylquinazoline",Investigative,CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CC3=CC=CC=C3)OCC
EGFR,Epidermal growth factor receptor (EGFR),D02FGG,AFM-21,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D02GCE,PD182905,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D02KVB,AG 112,Investigative,C1=CC(=CC=C1C=C(C#N)C(=C(C#N)C#N)N)O
EGFR,Epidermal growth factor receptor (EGFR),D02RIG,"2-(4,5-Dihydroxy-indan-1-ylidene)-malononitrile",Investigative,C1CC(=C(C#N)C#N)C2=C1C(=C(C=C2)O)O
EGFR,Epidermal growth factor receptor (EGFR),D02ZRO,(3-Bromo-phenyl)-quinazolin-4-yl-amine,Investigative,C1=CC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D03ATU,PD-158780,Investigative,CNC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D03BJB,EGFR inhibitor,Investigative,C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)F
EGFR,Epidermal growth factor receptor (EGFR),D03CVQ,"6,7-diethoxy-4-(4-phenylbut-1-enyl)quinazoline",Investigative,CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CCCC3=CC=CC=C3)OCC
EGFR,Epidermal growth factor receptor (EGFR),D03MTY,LA22-radioimmunoconjugates,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D03WEN,5-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide,Investigative,C=CC(=O)NC1=CC(=C(C=C1)O)C(=O)NC2=CC(=CC=C2)Br
EGFR,Epidermal growth factor receptor (EGFR),D03ZIW,ICR 62,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D04GCH,Bmab-200,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D04HGN,HTS-00213,Investigative,C1=CC(=C(C(=C1)Cl)OCC2=NOC(=N2)CSC3=NN=CN3C4=CC=C(C=C4)C(F)(F)F)Cl
EGFR,Epidermal growth factor receptor (EGFR),D04LXG,"6,7-diethoxy-4-(5-phenylpent-1-enyl)quinazoline",Investigative,CCOC1=C(C=C2C(=C1)C(=NC=N2)C=CCCCC3=CC=CC=C3)OCC
EGFR,Epidermal growth factor receptor (EGFR),D05ARF,"N*4*-Benzyl-pyrido[4,3-d]pyrimidine-4,7-diamine",Investigative,C1=CC=C(C=C1)CNC2=NC=NC3=CC(=NC=C32)N
EGFR,Epidermal growth factor receptor (EGFR),D05MEY,Epitinib,Investigative,CCN1CCN(CC1)C(=O)NC2=C(C=C3C(=C2)C(=NC=N3)NC4=CC=CC(=C4)C#C)OC
EGFR,Epidermal growth factor receptor (EGFR),D06QEQ,OSI-75,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D06UEK,(E)-5-(4-Hydroxybenzylidene)-1-phenethylhydantoin,Investigative,C1=CC=C(C=C1)CCN2C(=CC3=CC=C(C=C3)O)C(=O)NC2=O
EGFR,Epidermal growth factor receptor (EGFR),D07CZM,HTS-02876,Investigative,C1=CC=C(C=C1)COC2=CC=C(C=C2)N3C(=O)NN=C3SCCS(=O)(=O)C4=CC=CC(=C4)C(F)(F)F
EGFR,Epidermal growth factor receptor (EGFR),D07IHD,"2-(5,6-Dihydroxy-indan-1-ylidene)-malononitrile",Investigative,C1CC(=C(C#N)C#N)C2=CC(=C(C=C21)O)O
EGFR,Epidermal growth factor receptor (EGFR),D07UYV,PMID8568816C56,Investigative,CCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OCC
EGFR,Epidermal growth factor receptor (EGFR),D08RXW,MT-062,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D09RXX,Anti-EGFR mab,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0A0JL,RG-50810,Investigative,C1=CC(=C(C=C1C=C(C#N)C#N)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0AC7C,IPS-01003,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0AH2V,RM-6427,Investigative,CCOC(=O)C1=C(C(=O)C2=C(C=C(C=C2O1)O)O)C3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D0B4PH,"N*4*-(3-Bromo-phenyl)-quinazoline-4,6,7-triamine",Investigative,C1=CC(=CC(=C1)Br)NC2=NC=NC3=CC(=C(C=C32)N)N
EGFR,Epidermal growth factor receptor (EGFR),D0B8DE,"3-Pyridin-4-yl-quinoline-6,7-diol",Investigative,C1=CN=CC=C1C2=CN=C3C=C(C(=CC3=C2)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0C5WE,AGT-2000,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0C9KC,"3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one",Investigative,C1=CC(=CC(=C1)Cl)C2=COC3=CC(=CC(=C3C2=O)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0CY9O,ON-128,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0D0GS,FHT-2107,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0D0YK,GI-3000,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0DF3Z,"6,7-dimethoxy-N-m-tolylquinazolin-4-amine",Investigative,CC1=CC(=CC=C1)NC2=NC=NC3=CC(=C(C=C32)OC)OC
EGFR,Epidermal growth factor receptor (EGFR),D0EH6L,"5,6-Bis-p-tolylamino-isoindole-1,3-dione",Investigative,CC1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=C(C=C4)C
EGFR,Epidermal growth factor receptor (EGFR),D0EP1G,HTS-05058,Investigative,C1=CC=C2C(=C1)C(=CC3=CN=CN3)C(=O)N2
EGFR,Epidermal growth factor receptor (EGFR),D0F6FZ,N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide,Investigative,CC1=CC(=CC=C1)NC2=NC=NC3=C2C=CC(=C3)NC(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D0G4HR,4-(4-(2-nitrovinyl)phenoxysulfonyl)benzoic acid,Investigative,C1=CC(=CC=C1C=C[N+](=O)[O-])OS(=O)(=O)C2=CC=C(C=C2)C(=O)O
EGFR,Epidermal growth factor receptor (EGFR),D0G9KD,Benzo[g]quinazolin-4-yl-(3-bromo-phenyl)-amine,Investigative,C1=CC=C2C=C3C(=CC2=C1)C(=NC=N3)NC4=CC(=CC=C4)Br
EGFR,Epidermal growth factor receptor (EGFR),D0GB7F,ARX-AHD,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0H3FX,TGF alpha,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0H3UI,AG 9,Investigative,COC1=CC=C(C=C1)C=C(C#N)C#N
EGFR,Epidermal growth factor receptor (EGFR),D0HM5W,"N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine",Investigative,C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=C(C=C3)N
EGFR,Epidermal growth factor receptor (EGFR),D0I7RA,"4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)C3=CNC4=C3C=C(C=C4)Br)OC
EGFR,Epidermal growth factor receptor (EGFR),D0J3EA,Theliatinib,Investigative,CN1CCC2C1CN(C2)C(=O)NC3=C(C=C4C(=C3)C(=NC=N4)NC5=CC=CC(=C5)C#C)OC
EGFR,Epidermal growth factor receptor (EGFR),D0J9WO,"4-(3-Bromo-phenylamino)-quinazoline-6,7-diol",Investigative,C1=CC(=CC(=C1)Br)NC2=C3C=C(C(=O)C=C3NC=N2)O
EGFR,Epidermal growth factor receptor (EGFR),D0K2VO,"6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)C#CCCC3=CC=CC=C3)OC
EGFR,Epidermal growth factor receptor (EGFR),D0K2YY,"4-(2-nitroprop-1-enyl)benzene-1,2-diol",Investigative,CC(=CC1=CC(=C(C=C1)O)O)[N+](=O)[O-]
EGFR,Epidermal growth factor receptor (EGFR),D0K3FG,EDP-13,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0K7GD,"N*4*-(3-Bromo-phenyl)-quinazoline-4,7-diamine",Investigative,C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C=CC(=C3)N
EGFR,Epidermal growth factor receptor (EGFR),D0KN1L,(S)-benzyl 4-chloro-3-oxobutan-2-ylcarbamate,Investigative,CC(C(=O)CCl)NC(=O)OCC1=CC=CC=C1
EGFR,Epidermal growth factor receptor (EGFR),D0L3SN,"4-(2-nitrovinyl)benzene-1,2-diol",Investigative,C1=CC(=C(C=C1C=C[N+](=O)[O-])O)O
EGFR,Epidermal growth factor receptor (EGFR),D0NH7M,AG-538,Investigative,C1=CC(=C(C=C1C=C(C#N)C(=O)C2=CC(=C(C=C2)O)O)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0NJ3Q,WZ-3146,Investigative,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)OC4=CC=CC(=C4)NC(=O)C=C)Cl
EGFR,Epidermal growth factor receptor (EGFR),D0O9UR,2-methoxy-4-(2-nitrovinyl)phenol,Investigative,COC1=C(C=CC(=C1)C=C[N+](=O)[O-])O
EGFR,Epidermal growth factor receptor (EGFR),D0P0JW,MG-111,Investigative,CCC(C)C(C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CS)C(=O)NC(CCC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(C(C)C)NC(=O)C(CS)NC(=O)C(CC(=O)N)NC(=O)C(CS)NC(=O)C(C)NC(=O)C(CC7=CC=C(C=C7)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)CC)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC9=CN=CN9)NC(=O)C(CC(C)C)NC(=O)C(CS)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(CS)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC(=O)N)N
EGFR,Epidermal growth factor receptor (EGFR),D0P2GE,"6,7-dimethoxy-4-(2-phenylethynyl)quinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)C#CC3=CC=CC=C3)OC
EGFR,Epidermal growth factor receptor (EGFR),D0R2RV,Anti-EGFR humanized mabs,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0S9QP,"4-biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)C#CC3=CC=CC=C3C4=CC=CC=C4)OC
EGFR,Epidermal growth factor receptor (EGFR),D0T7OS,AL-6802,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0U6WB,BPIQ-I,Investigative,CN1C=NC2=C1C=C3C(=C2)C(=NC=N3)NC4=CC(=CC=C4)Br
EGFR,Epidermal growth factor receptor (EGFR),D0V0JV,mabionHER2,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0W1BE,4-(2-nitrovinyl)phenol,Investigative,C1=CC(=CC=C1C=C[N+](=O)[O-])O
EGFR,Epidermal growth factor receptor (EGFR),D0W2PQ,4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide,Investigative,C=CC(=O)NC1=CC(=C(C=C1)C(=O)NC2=CC(=CC=C2)Br)O
EGFR,Epidermal growth factor receptor (EGFR),D0WD8R,MDP-01,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0X4UE,"N4-(3-methylphenyl)-4,6-quinazolinediamine",Investigative,CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)N
EGFR,Epidermal growth factor receptor (EGFR),D0Y1LD,RX-1792,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0Y2AM,(3-Bromo-phenyl)-(5-nitro-quinazolin-4-yl)-amine,Investigative,C1=CC(=CC(=C1)Br)NC2=NC=NC3=C2C(=CC=C3)[N+](=O)[O-]
EGFR,Epidermal growth factor receptor (EGFR),D0Y6MD,NRC-2694,Investigative,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4
EGFR,Epidermal growth factor receptor (EGFR),D0ZT9D,Cochliobolic acid,Investigative,CCC(C)C=CC(=O)C(=O)C=CC=CC=CC=CC=CC=CC1CC(C(O1)C(=O)O)O
EGFR,Epidermal growth factor receptor (EGFR),D01VFR,PD-168393,Investigative,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D01WYI,N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide,Investigative,CC1=CC(=CC=C1)NC2=NC=NC3=C2C=C(C=C3)NC(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D03HLH,"4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline",Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)OC3=CC(=CC=C3)Br)OC
EGFR,Epidermal growth factor receptor (EGFR),D05QMN,"4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline",Investigative,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D0AM9O,YH013,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0D9TU,LAVENDUSTIN A,Investigative,C1=CC=C(C(=C1)CN(CC2=C(C=CC(=C2)O)O)C3=CC(=C(C=C3)O)C(=O)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0J2CP,PF 5208766,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0J5SK,6-chloro-N-(3-chlorophenyl)quinazolin-4-amine,Investigative,C1=CC(=CC(=C1)Cl)NC2=NC=NC3=C2C=C(C=C3)Cl
EGFR,Epidermal growth factor receptor (EGFR),D0N8TQ,N-(4-(phenylamino)quinazolin-6-yl)acrylamide,Investigative,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC=CC=C3
EGFR,Epidermal growth factor receptor (EGFR),D0Q3GG,AG-213,Investigative,C1=CC(=C(C=C1C=C(C#N)C(=S)N)O)O
EGFR,Epidermal growth factor receptor (EGFR),D0Q8GX,SYM-011,Investigative,
EGFR,Epidermal growth factor receptor (EGFR),D0W6CE,10-hydroxy-18-methoxybetaenone,Investigative,CCC(C)C1C(C2C(CC(CC2(C(=O)C1(C)O)O)(C)O)C)(C)C(=O)C=COC
EGFR,Epidermal growth factor receptor (EGFR),D0X4OU,4557W,Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OCC4=CC=CC=C4)OC
EGFR,Epidermal growth factor receptor (EGFR),D0ZH1U,Tyrphostin ag-1478,Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC
EGFR,Epidermal growth factor receptor (EGFR),D00TZD,CL-387785,Investigative,CC#CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=CC=C3)Br
EGFR,Epidermal growth factor receptor (EGFR),D05FFT,HDS-029,Investigative,CC#CC(=O)NC1=NC=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl
EGFR,Epidermal growth factor receptor (EGFR),D0E5IP,WHI-P154,Investigative,COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)O)Br)OC
EGFR,Epidermal growth factor receptor (EGFR),D06BJG,PMID24915291C38,Investigative,CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)C(=O)NC3=CN=C(N=C3)NC4=CC(=CC=C4)NC(=O)CNC(=O)C=C
EGFR,Epidermal growth factor receptor (EGFR),D0D5EW,HKI-9924129,Investigative,CC1=C(C=CC(=C1)NC2=NC=C3C=C(C(=O)N(C3=N2)C)C4=C(C=CC=C4Cl)Cl)F
EGFR,Epidermal growth factor receptor (EGFR),D0GW4Q,PD-0173956,Investigative,CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC=C(C=C4)F
EGFR,Epidermal growth factor receptor (EGFR),D0P3JW,PD-0166326,Investigative,CN1C2=NC(=NC=C2C=C(C1=O)C3=C(C=CC=C3Cl)Cl)NC4=CC=CC(=C4)CO
EGFR,Epidermal growth factor receptor (EGFR),D03EHM,PP121,Investigative,C1CCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CN=C5C(=C4)C=CN5)N
EGFR,Epidermal growth factor receptor (EGFR),D06AOY,"3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione",Investigative,C1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CNC4=CC=CC=C43
EGFR,Epidermal growth factor receptor (EGFR),D09XIL,Ro-4396686,Investigative,COC1=CC=C(C=C1)N2CC3=CN=C(N=C3N(C2=O)C4CCC(C4)O)NC5=CC=C(C=C5)F
EGFR,Epidermal growth factor receptor (EGFR),D00NYT,"3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione",Investigative,COC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=C(C=C3)OC
EGFR,Epidermal growth factor receptor (EGFR),D0C3WY,"3,4-diphenyl-1H-pyrrole-2,5-dione",Investigative,C1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3
EGFR,Epidermal growth factor receptor (EGFR),D0EK0G,"3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione",Investigative,COC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3
EGFR,EGFR T790M mutant (EGFR T790M),D0O8GK,Osimertinib,Approved,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
EGFR,EGFR T790M mutant (EGFR T790M),D01DBB,PMID27774824-Compound-Figure9Example2down,Patented,
EGFR,EGFR Exon20ins mutant (EGFR Exon20ins),DI4HA7,Mobocertinib,Approved,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC
EGFR,EGFR Exon20ins mutant (EGFR Exon20ins),DM8Y2N,DZD9008,Phase 1/2,
EGFR,EGFR messenger RNA (EGFR mRNA),D0FV3K,AC0010,Phase 3,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F
EGFR,EGFR messenger RNA (EGFR mRNA),D06VFF,EGFR antisense DNA,Phase 1/2,
EGFR,EGFR messenger RNA (EGFR mRNA),D09BZS,CK-101,Phase 1/2,C=CC(=O)NC1=CC=CC(=C1)C2=CC=CC3=CN=C(N=C32)NC4=C(C(=C(C=C4)N5CCN(CC5)CCO)F)F
EGFR,EGFR messenger RNA (EGFR mRNA),D0M8YM,Pyrotinib,Phase 1,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D08RJY,Anti-EGFRvIII CAR transduced PBL,Phase 1/2,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D0LU4N,EGFRvIII CAR,Phase 1/2,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D0Q4EJ,Anti-EGFR V III CAR-T cells,Phase 1/2,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D01LWE,EGFRvIII CAR T cells,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D03CMZ,CAR-T cells targeting EGFRviii,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D09OSC,Anti-EGFRvIII CAR T cells,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D0B5PV,CART-EGFRvIII T cells,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D0PT2M,EGFRvIII-CARs,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),D0ZQ6N,CAR-T Cells targeting EGFRvIII,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),DF8X5N,RG6156,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),DOJ6E8,AMG 596,Phase 1,
EGFR,Epidermal growth factor receptor variant III (EGFR vIII),DR4ND6,D2C7,Phase 1,
HDAC1,Histone deacetylase 1 (HDAC1),D0E3SH,Panobinostat,Approved,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0E7PQ,Vorinostat,Approved,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0L7LC,Romidepsin,Approved,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C
HDAC1,Histone deacetylase 1 (HDAC1),D00SQN,HBI-8000,Registered,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N
HDAC1,Histone deacetylase 1 (HDAC1),D0B3FV,NVP-LAQ824,Phase 3,C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0M8FD,SNDX-275,Phase 3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3
HDAC1,Histone deacetylase 1 (HDAC1),D0GH3Q,ITF2357,Phase 3,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01UXJ,Resminostat,Phase 2,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0I7IB,Sodium butyrate,Phase 2,CCCC(=O)[O-].[Na+]
HDAC1,Histone deacetylase 1 (HDAC1),D0VE1W,SB-623,Phase 2,CCN(CC)CCN1C2=C(C=C(C=C2)C=CC(=O)NO)N=C1CCC3=CC=CC=C3
HDAC1,Histone deacetylase 1 (HDAC1),D00FHR,MGCD-0103,Phase 2,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4
HDAC1,Histone deacetylase 1 (HDAC1),D0B7CH,Phenylbutyrate,Phase 2,C1=CC=C(C=C1)CCCC(=O)O
HDAC1,Histone deacetylase 1 (HDAC1),D06TKI,CHR-3996,Phase 1/2,C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D07FPY,SB-639,Phase 1,C1CCN(C1)CCN2C3=C(C=C(C=C3)C=CC(=O)NO)N=C2CCC4=CC=CC=C4
HDAC1,Histone deacetylase 1 (HDAC1),D0GE5B,RG-2833,Phase 1,CC1=CC=C(C=C1)C(=O)NCCCCCC(=O)NC2=CC=CC=C2N
HDAC1,Histone deacetylase 1 (HDAC1),D00SSZ,OBP-801,Phase 1,CC1C(=O)NC2CSSCCC=CC(CC(=O)N1)OC(=O)CC(C(NC2=O)C(C)C)O
HDAC1,Histone deacetylase 1 (HDAC1),D0YT8O,PMID29671355-Compound-42,Patented,CC(C)N1C=NC2=C(N=C(N=C21)N3CCOCC3)C4=CC(=CC=C4)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D00ACL,PMID28092474-Compound-33d,Patented,C1=CC(=C(C=C1C(=O)NO)F)CN(C2=NC=CN=C2)C3=NC=CN=C3
HDAC1,Histone deacetylase 1 (HDAC1),D00GLJ,PMID28092474-Compound-32u,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D00LLN,PMID28092474-Compound-33a,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D00XWZ,PMID28092474-Compound-32a,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D01LCZ,PMID28092474-Compound-32j,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D02YDG,PMID28092474-Compound-32z,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D03EUD,PMID28092474-Compound-32g,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D04AMI,PMID28092474-Compound-34c,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D04KQU,PMID28092474-Compound-32x,Patented,COC1=CN=C(C=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)N4CCOCC4
HDAC1,Histone deacetylase 1 (HDAC1),D04MVN,PMID28092474-Compound-33b,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D04VQE,PMID28092474-Compound-32b,Patented,CC1=NOC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC=N3
HDAC1,Histone deacetylase 1 (HDAC1),D06IIL,PMID28092474-Compound-32o,Patented,CN1C=CC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F
HDAC1,Histone deacetylase 1 (HDAC1),D08GBR,PMID28092474-Compound-33g,Patented,COC1=C(N=CC=C1)N(CC2=C(C=C(C=C2)C(=O)NO)F)C3=NC=CN=C3
HDAC1,Histone deacetylase 1 (HDAC1),D08GQL,PMID28092474-Compound-33j,Patented,C1=CC(=NN=C1)N(CC2=C(C=C(C=C2)C(=O)NO)F)C3=NC=CN=C3
HDAC1,Histone deacetylase 1 (HDAC1),D08SNJ,PMID28092474-Compound-33p,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D08XLK,PMID28092474-Compound-33m,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D08ZJZ,PMID28092474-Compound-32v,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D09PVH,PMID29671355-Compound-24,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0BY1R,PMID28092474-Compound-34b,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0CH4M,PMID28092474-Compound-33e,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0CX1Y,PMID28092474-Compound-32t,Patented,CC1=CN=C(C=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=C(C=CC=N3)OC
HDAC1,Histone deacetylase 1 (HDAC1),D0DH7R,PMID28092474-Compound-32c,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0E5CO,PMID28092474-Compound-33i,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0ET4U,PMID28092474-Compound-32r,Patented,CN1C2=CC=CC=C2N=C1N(CC3=CC=C(C=C3)C(=O)NO)C4=NC=C(C=C4)F
HDAC1,Histone deacetylase 1 (HDAC1),D0EU5A,PMID28092474-Compound-32h,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0F3TB,PMID29671355-Compound-65a,Patented,C1=CC2=C(C(=C1)NCCCCCNC(=O)CS)N=CC=C2
HDAC1,Histone deacetylase 1 (HDAC1),D0HM6Y,PMID28092474-Compound-32y,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0JN0A,PMID28092474-Compound-33h,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0JR9L,PMID29671355-Compound-38a,Patented,C1=CN=C(C=N1)N(CCCCCCC(=O)NO)C2=CN=CN=C2
HDAC1,Histone deacetylase 1 (HDAC1),D0K2UF,PMID28092474-Compound-33f,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0KA3X,Diaryl amine derivative 3,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0L3CU,PMID28092474-Compound-33c,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0L7HG,PMID29671355-Compound-39,Patented,C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)NCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0LV6K,PMID29671355-Compound-19,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0M7XL,PMID28092474-Compound-32e,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0MQ2D,PMID28092474-Compound-32m,Patented,C1=CC(=CC=C1CN(C2=NC=C(C=C2)F)C3=NC=CN=C3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0MR7U,PMID28092474-Compound-32p,Patented,CC1=NSC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F
HDAC1,Histone deacetylase 1 (HDAC1),D0N1RX,PMID28092474-Compound-32d,Patented,C1=CC=NC(=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NN=CS3
HDAC1,Histone deacetylase 1 (HDAC1),D0O6SJ,PMID28092474-Compound-32n,Patented,CC1=NOC(=N1)N(CC2=CC=C(C=C2)C(=O)NO)C3=NC=C(C=C3)F
HDAC1,Histone deacetylase 1 (HDAC1),D0Q9XK,PMID28092474-Compound-33k,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0QF0Y,PMID28092474-Compound-32k,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0QN8W,PMID28092474-Compound-34a,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0QR1Z,Isosteric imidazolyl pyrimidine derivative 1,Patented,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(S3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0QX3G,PMID29671355-Compound-22,Patented,C1=CC=C(C=C1)N(CCO)C(=O)CC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0R3RJ,PMID29671355-Compound-26,Patented,C1CN(C2=CC=CC=C2N1)CC3=CC=C(C=C3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0RD7T,PMID28092474-Compound-33o,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0S3ZB,PMID28092474-Compound-32f,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0S7NE,Diaryl amine derivative 2,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0SF8N,PMID28092474-Compound-33l,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0SK9K,PMID28092474-Compound-32i,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0TH3L,PMID28092474-Compound-32q,Patented,C1=CC(=CC=C1CN(C2=NC=C(C=C2)F)C3=NC(=NS3)C(F)(F)F)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0TN6E,PMID29671355-Compound-18,Patented,C1=CC=NC(=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC=N3
HDAC1,Histone deacetylase 1 (HDAC1),D0UD9R,PMID29671355-Compound-57,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0V5IQ,PMID29671355-Compound-27,Patented,CCN1C=NC(=C1C2=CC=C(C=C2)C=CC(=O)NO)C3=CC=C(C=C3)OC
HDAC1,Histone deacetylase 1 (HDAC1),D0W1AX,PMID28092474-Compound-32l,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0YC2M,PMID28092474-Compound-32s,Patented,C1=CC=C2C(=C1)N=C(O2)N(CC3=CC=C(C=C3)C(=O)NO)C4=NC=C(C=C4)F
HDAC1,Histone deacetylase 1 (HDAC1),D0YD7B,PMID29671355-Compound-38b,Patented,CC1=NSC(=N1)N(CCCCCCC(=O)NO)C2=CC=CC=N2
HDAC1,Histone deacetylase 1 (HDAC1),D0Z7QI,PMID29671355-Compound-28,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0C9NX,PMID29671355-Compound-59,Patented,C1CN(CCN1)C2=CC3=CN=C(C=C3C=C2)C(=O)NC4=C(C=CC(=C4)C5=CC=CS5)N
HDAC1,Histone deacetylase 1 (HDAC1),D0OU0J,PMID29671355-Compound-55,Patented,C1C(=CC2=CC=C(C=C2)C(=O)NC3=CC=CC=C3N)CN1CC4=CC5=C(C=C4)C=CN5
HDAC1,Histone deacetylase 1 (HDAC1),D0T7OQ,PMID29671355-Compound-73,Patented,C1C2=C(C=CC(=C2)C3=NOC(=N3)C(F)(F)F)C(=O)N1C4=CC=CC=C4
HDAC1,Histone deacetylase 1 (HDAC1),D0ZG5X,PMID29671355-Compound-13,Patented,CCC1=NC2=C(C=C(C=C2)CC3=CC=C(C=C3)C(=O)NO)C(=O)N1CCC4=CC=CC=C4
HDAC1,Histone deacetylase 1 (HDAC1),D0EH2K,PMID29671355-Compound-11,Patented,COC1=CC=C(C=C1)NC(=O)N2CCC(CC2)(C3=CC=CC=C3)NC4=NC=C(C=N4)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0Q1QY,PMID29671355-Compound-9,Patented,C1CC1(C2=CC=CC=C2)NC3=NC=C(C=N3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0LN1T,PMID29671355-Compound-8,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0JB4S,PMID29671355-Compound-61,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D00HXJ,PMID29671355-Compound-23,Patented,CN1C(=O)C2CN(C1=O)CC3=C2C4=CC=CC=C4N3CC5=CC=C(C=C5)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0N2DK,PMID29671355-Compound-44,Patented,C1CC(=O)NC1C(=O)NC(CCCCCC(=O)NO)C(=O)NC2=CC=CC(=C2)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D0CH8Q,PMID29671355-Compound-56,Patented,C=C1CN(C(=O)C2=CC=CC=C12)CC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N
HDAC1,Histone deacetylase 1 (HDAC1),D0M0RE,PMID29671355-Compound-67,Patented,C1CN=C2C3=C(C=C(C=C3)F)SC(=N)N2C1
HDAC1,Histone deacetylase 1 (HDAC1),D0DI9S,PMID29671355-Compound-31,Patented,CN(CC1=CC=C(C=C1)C=CC(=O)NO)CC23CC4CC(C2)CC(C4)C3
HDAC1,Histone deacetylase 1 (HDAC1),D0LP1K,PMID29671355-Compound-21,Patented,C1COCCN1C(=O)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC(=C3)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D07WAT,PMID29671355-Compound-62,Patented,
HDAC1,Histone deacetylase 1 (HDAC1),D0BP8I,PMID29671355-Compound-43,Patented,CN1C=NC2=C1C(=NC(=N2)NC3=CC=C(C=C3)OCCCCCCC(=O)NO)NC4CCCCC4
HDAC1,Histone deacetylase 1 (HDAC1),D0RA0D,PMID29671355-Compound-25,Patented,C1=CC2=C(N=C1)SN(C2=O)CC3=CC=C(C=C3)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0MP2U,AN-9,Discontinued in Phase 2,CCCC(=O)OCOC(=O)C(C)(C)C
HDAC1,Histone deacetylase 1 (HDAC1),D0W9NH,Tacedinaline,Discontinued in Phase 2,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N
HDAC1,Histone deacetylase 1 (HDAC1),D0N3SH,Pyroxamide,Discontinued in Phase 1,C1=CC(=CN=C1)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03SZR,M-carboxycinnamic acid bishydroxamide,Preclinical,C1=CC(=CC(=C1)C(=O)NO)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06RQU,HC-Toxin,Preclinical,CC1C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C)CCCCCC(=O)C3CO3
HDAC1,Histone deacetylase 1 (HDAC1),D0DO5U,SK-7068,Preclinical,C1CCN(C1)C2=CC=C(C=C2)C(=O)NCC3=CC=C(C=C3)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0J8OC,Scriptaid,Preclinical,C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0L5DZ,4SC-202,Preclinical,CC1=CC=C(C=C1)S(=O)(=O)O.CN1C=C(C=N1)C2=CC=C(C=C2)S(=O)(=O)N3C=CC(=C3)C=CC(=O)NC4=CC=CC=C4N
HDAC1,Histone deacetylase 1 (HDAC1),D0UC6H,Chlamydocin,Preclinical,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCC(=O)C3CO3)CC4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D0UL5X,SK-7041,Preclinical,CN(C)C1=CC=C(C=C1)C(=O)NCC2=CC=C(C=C2)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0W8JE,Depudecin,Preclinical,CC(C1C(O1)C=CC2C(O2)C(C=C)O)O
HDAC1,Histone deacetylase 1 (HDAC1),D03YVR,Oxamflatin,Terminated,C1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC(=C2)C#CC=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D00GBB,6-(3-Benzoyl-ureido)-hexanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D00LSZ,"N,8-dihydroxy-8-(naphthalen-2-yl)octanamide",Investigative,C1=CC=C2C=C(C=CC2=C1)C(CCCCCCC(=O)NO)O
HDAC1,Histone deacetylase 1 (HDAC1),D00PLM,N-hydroxy-5-(pyridin-3-yl)thiophene-2-carboxamide,Investigative,C1=CC(=CN=C1)C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D00RGD,N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide,Investigative,C1=CC(=CN=C1)C(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01EDB,NSC-746457,Investigative,C1=CC=C(C=C1)C=CCN2C=C(N=N2)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D02VVU,4-Benzenesulfonylamino-N-hydroxy-benzamide,Investigative,C1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03FFI,N-hydroxy-7-(naphthalen-2-yl)-7-oxoheptanamide,Investigative,C1=CC=C2C=C(C=CC2=C1)C(=O)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03FOD,4-tert-butyl-N-hydroxybenzamide,Investigative,CC(C)(C)C1=CC=C(C=C1)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03OYL,N-hydroxy-7-(naphthalen-2-yloxy)heptanamide,Investigative,C1=CC=C2C=C(C=CC2=C1)OCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03ZUZ,8-(3-Benzoyl-ureido)-octanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D04XPZ,N-hydroxy-8-(naphthalen-2-yl)non-8-enamide,Investigative,C=C(CCCCCCC(=O)NO)C1=CC2=CC=CC=C2C=C1
HDAC1,Histone deacetylase 1 (HDAC1),D05PYF,N-hydroxy-5-(pyridin-2-yl)thiophene-2-carboxamide,Investigative,C1=CC=NC(=C1)C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06NVX,N-hydroxy-5-phenylthiophene-2-carboxamide,Investigative,C1=CC=C(C=C1)C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06ONC,Azithromycin-N-benzyltriazolyldecahydroxamic Acid,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D07HUH,7-(4-(dimethylamino)phenoxy)-N-hydroxyheptanamide,Investigative,CN(C)C1=CC=C(C=C1)OCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0A6CB,8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0A7IF,N-hydroxy-5-(pyridin-4-yl)thiophene-2-carboxamide,Investigative,C1=CN=CC=C1C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0B1YM,Gymnochrome E,Investigative,CCCC(CC1=C2C3=C(C(=C(C4=C(C5=C6C(=C7C(=O)C=C(C8=C7C(=C2C(=C8O)C(=C1Br)O)C6=C34)O)C(=O)C=C5O)O)O)Br)CC(C)O)O
HDAC1,Histone deacetylase 1 (HDAC1),D0CJ7L,N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide,Investigative,C1=CC=C2C=C(C=CC2=C1)C=CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0D3XC,N-hydroxybenzo[b]thiophene-2-carboxamide,Investigative,C1=CC=C2C(=C1)C=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0G0OF,7-(1H-indol-5-yloxy)-N-hydroxyheptanamide,Investigative,C1=CC2=C(C=CN2)C=C1OCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0GJ1E,8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide,Investigative,C1=CC(=CC=C1C(=O)CCCCCCC(=O)NO)Br
HDAC1,Histone deacetylase 1 (HDAC1),D0K8MF,N-hydroxy-7-(4-methoxyphenyl)-7-oxoheptanamide,Investigative,COC1=CC=C(C=C1)C(=O)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0KM7H,N-hydroxy-8-(2-methoxyphenyl)-8-oxooctanamide,Investigative,COC1=CC=CC=C1C(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0L4ML,N-hydroxy-6-oxo-6-phenylhexanamide,Investigative,C1=CC=C(C=C1)C(=O)CCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0L5WI,N-hydroxy-8-(naphthalen-2-yl)octanamide,Investigative,C1=CC=C2C=C(C=CC2=C1)CCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0M0QJ,ADS-102550,Investigative,C1OC2=C(O1)C=C(C=C2)CNCCN3C=CC(=N3)C4=CC=C(S4)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0O7UF,N-hydroxy-8-(4-methoxyphenyl)-8-oxooctanamide,Investigative,COC1=CC=C(C=C1)C(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0P1RQ,N-(2-aminophenyl)-4-(chroman-3-ylmethyl)benzamide,Investigative,C1C(COC2=CC=CC=C21)CC3=CC=C(C=C3)C(=O)NC4=CC=CC=C4N
HDAC1,Histone deacetylase 1 (HDAC1),D0PP3Q,"N-hydroxy-2,2'-bithiophene-5-carboxamide",Investigative,C1=CSC(=C1)C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0Q8QA,ADS-100380,Investigative,CN1C(=CC(=N1)C(F)(F)F)C2=CC=C(S2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0QX6R,N-hydroxy-7-oxo-7-phenylheptanamide,Investigative,C1=CC=C(C=C1)C(=O)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0T0BE,7-(3-Benzoyl-ureido)-heptanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C(=O)NC(=O)NCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0U3MB,SK-683,Investigative,C1=CC=C(C=C1)NC(=O)C(C2=CC=CC(=C2)C=CC(=O)NO)C(=O)NC3=CC=CC=C3
HDAC1,Histone deacetylase 1 (HDAC1),D0Z2VP,N-hydroxy-9-oxo-9-phenylnonanamide,Investigative,C1=CC=C(C=C1)C(=O)CCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D00HFS,N-Hydroxy-N'-(4-methylphenyl)octanediamide,Investigative,CC1=CC=C(C=C1)NC(=O)CCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01AMS,"N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=C(C(=CC=C1)NC(=O)CCCCCCC(=O)NO)C
HDAC1,Histone deacetylase 1 (HDAC1),D01FYB,N-(2-aminophenyl)quinoxaline-6-carboxamide,Investigative,C1=CC=C(C(=C1)N)NC(=O)C2=CC3=NC=CN=C3C=C2
HDAC1,Histone deacetylase 1 (HDAC1),D01RJY,7-Biphenyl-4-yl-heptanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01ZMJ,N-(2-Ethylphenyl)-N'-hydroxyoctanediamide,Investigative,CCC1=CC=CC=C1NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D03XXI,8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C(=O)O
HDAC1,Histone deacetylase 1 (HDAC1),D04ETX,"1,1,1-Trifluoro-8-phenoxy-octan-2-one",Investigative,C1=CC=C(C=C1)OCCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D04LLD,7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D05GRZ,"N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=CC(=C(C=C1)NC(=O)CCCCCCC(=O)NO)C
HDAC1,Histone deacetylase 1 (HDAC1),D05ZGM,7-Phenoxy-heptanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)OCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06BKA,"1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one",Investigative,C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D06FAK,6-(9H-carbazol-9-yl)-N-hydroxyhexanamide,Investigative,C1=CC=C2C(=C1)C3=CC=CC=C3N2CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06THS,Desclasinose Azithromycinarylalkyl Hydroxamate,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)O)C)OC2C(C(CC(O2)C)N(C)CC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D08ICY,N-(4-Ethylphenyl)-N'-hydroxyoctanediamide,Investigative,CCC1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D08TIJ,"N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=CC(=CC(=C1)NC(=O)CCCCCCC(=O)NO)C
HDAC1,Histone deacetylase 1 (HDAC1),D08XMS,N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide,Investigative,C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0B8RC,"N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=CC(=C(C=C1)C)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0D7KH,Azithromycin-N-benzyltriazolyloctahydroxamic Acid,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D0E0TA,N-(4-hydroxybiphenyl-3-yl)benzamide,Investigative,C1=CC=C(C=C1)C2=CC(=C(C=C2)O)NC(=O)C3=CC=CC=C3
HDAC1,Histone deacetylase 1 (HDAC1),D0E9DD,AZUMAMIDE E,Investigative,CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=CC=C2)CC=CCCC(=O)O
HDAC1,Histone deacetylase 1 (HDAC1),D0H3RO,Azithromycin-N-benzyltriazolylnonahydroxamic Acid,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D0H7QA,N-Hydroxy-N'-(3-methylphenyl)octanediamide,Investigative,CC1=CC(=CC=C1)NC(=O)CCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0H9DS,8-Phenyl-octanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)CCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0I5XM,Azithromycin-N-benzyltriazolylhexahydroxamic Acid,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)C5=CN(N=N5)CCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D0J3CY,N-(3-Ethylphenyl)-N'-hydroxyoctanediamide,Investigative,CCC1=CC(=CC=C1)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0L5KP,"N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=C(C=C(C=C1)NC(=O)CCCCCCC(=O)NO)C
HDAC1,Histone deacetylase 1 (HDAC1),D0L6YF,N-Hydroxy-N'-(4-methoxyphenyl)octanediamide,Investigative,COC1=CC=C(C=C1)NC(=O)CCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0M1ZI,AZUMAMIDE B,Investigative,CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=C(C=C2)O)CC=CCCC(=O)N
HDAC1,Histone deacetylase 1 (HDAC1),D0NL6C,"8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one",Investigative,C1=CC=C(C=C1)C2=CC(=CC=C2)OCCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D0P9CQ,Azithromycinarylalkylhydroxamic Acid,Investigative,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)CC4=CC=C(C=C4)NC(=O)CCCCCCC(=O)NO)O)(C)O)C)C)C)O)(C)O
HDAC1,Histone deacetylase 1 (HDAC1),D0Q2CC,N-Hydroxy-N'-(2-methylphenyl)octanediamide,Investigative,CC1=CC=CC=C1NC(=O)CCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0Q5DI,nexturastat A,Investigative,CCCCN(CC1=CC=C(C=C1)C(=O)NO)C(=O)NC2=CC=CC=C2
HDAC1,Histone deacetylase 1 (HDAC1),D0Q9PO,AZUMAMIDE C,Investigative,CC1C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)C(C)C)C)CC2=CC=C(C=C2)O)CC=CCCC(=O)O
HDAC1,Histone deacetylase 1 (HDAC1),D0SQ1F,"N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide",Investigative,CC1=C(C(=CC=C1)C)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0YP4F,N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide,Investigative,C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0Z8PX,LARGAZOLE,Investigative,CCCCCCCC(=O)SCCC=CC1CC(=O)NCC2=NC(=CS2)C3=NC(CS3)(C(=O)NC(C(=O)O1)C(C)C)C
HDAC1,Histone deacetylase 1 (HDAC1),D00XTC,Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CCC4=CC=CC=C43)C(=O)N1)CCCCCSSC5=CC=CC=N5
HDAC1,Histone deacetylase 1 (HDAC1),D02HVH,7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide,Investigative,C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D02NAF,Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CCC4=CC=CC=C43)C(=O)N1)CCCCCSSC5=CC=CC=N5
HDAC1,Histone deacetylase 1 (HDAC1),D02NVY,Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC3(CC4=CC=CC=C4C3)C(=O)N1)CCCCCSSC5=CC=CC=N5
HDAC1,Histone deacetylase 1 (HDAC1),D03PRG,Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CCCC4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D04CDZ,Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)CC3=CC=CC=C3)CCCCCSSC4=CC=CC=N4
HDAC1,Histone deacetylase 1 (HDAC1),D04DOL,N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D04UVL,N-(2-aminophenyl)nicotinamide,Investigative,C1=CC=C(C(=C1)N)NC(=O)C2=CN=CC=C2
HDAC1,Histone deacetylase 1 (HDAC1),D0E8UH,Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)COCC4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D0G1EX,Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)C4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D0M9LJ,N-(4-aminobiphenyl-3-yl)nicotinamide,Investigative,C1=CC=C(C=C1)C2=CC(=C(C=C2)N)NC(=O)C3=CN=CC=C3
HDAC1,Histone deacetylase 1 (HDAC1),D0N5RV,Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-),Investigative,CC1CN2CC3=CC=CC=C3CC2C(=O)NC(C(=O)NC(C(=O)N1)(C)C)CCCCCSSC4=CC=CC=N4
HDAC1,Histone deacetylase 1 (HDAC1),D0Q2GM,N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide,Investigative,C1=CC(=CN=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=CS3)N
HDAC1,Histone deacetylase 1 (HDAC1),D0R3XO,Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)C)CCCCCSSC3=CC=CC=N3
HDAC1,Histone deacetylase 1 (HDAC1),D0U0EZ,Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CO)C
HDAC1,Histone deacetylase 1 (HDAC1),D0X4QC,Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CCC4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D0YO6M,N-(2-aminophenyl)-4-methoxybenzamide,Investigative,COC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N
HDAC1,Histone deacetylase 1 (HDAC1),D0Z6HR,Cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-),Investigative,CC1C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)N1)(C)CC3=CC=CC=C3)CCCCCSSC4=CC=CC=N4
HDAC1,Histone deacetylase 1 (HDAC1),D0Z6MI,Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-),Investigative,CC1(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)CCCCCSSC3=CC=CC=N3)CC4=CC=CC=C4)C
HDAC1,Histone deacetylase 1 (HDAC1),D02NWS,4-Phenylbutyrohydroxamic acid,Investigative,C1=CC=C(C=C1)CCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0S0WK,8-Oxo-8-phenyl-octanoic acid hydroxyamide,Investigative,C1=CC=C(C=C1)C(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01YBR,ST-3050,Investigative,C1COCCN1CCON=CC2=CC=C(C=C2)C=CC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D07YZZ,Octanedioic acid bis-hydroxyamide,Investigative,C(CCCC(=O)NO)CCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0N9AK,ST-2986,Investigative,C1=CC(=CC=C1C=CC(=O)NO)C=NOCC2=C(C(=C(C(=C2F)F)F)F)F
HDAC1,Histone deacetylase 1 (HDAC1),D00KFF,"9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide",Investigative,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D00SEE,7-Mercapto-heptanoic acid phenylamide,Investigative,C1=CC=C(C=C1)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D00ZSD,6-benzenesulfinylhexanoic acid hydroxamide,Investigative,C1=CC=C(C=C1)S(=O)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D01MFV,N-(2-Mercapto-ethyl)-N'-phenyl-succinamide,Investigative,C1=CC=C(C=C1)NC(=O)CCC(=O)NCCS
HDAC1,Histone deacetylase 1 (HDAC1),D01XWZ,7-Mercapto-heptanoic acid biphenyl-4-ylamide,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D01XXN,N-Hydroxy-4-phenylacetylamino-benzamide,Investigative,C1=CC=C(C=C1)CC(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D02MQM,6-(2-Bromo-acetylamino)-hexanoic acid phenylamide,Investigative,C1=CC=C(C=C1)NC(=O)CCCCCNC(=O)CBr
HDAC1,Histone deacetylase 1 (HDAC1),D02UTC,N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide,Investigative,C1=CC=C(C=C1)CC(=O)NCC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D02WZK,7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C3=NC=CO3
HDAC1,Histone deacetylase 1 (HDAC1),D04GGW,Octanedioic acid hydroxyamide pyridin-4-ylamide,Investigative,C1=CN=CC=C1NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D04HSS,N-(6-Mercapto-hexyl)-benzamide,Investigative,C1=CC=C(C=C1)C(=O)NCCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D04NSP,4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide,Investigative,C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)O
HDAC1,Histone deacetylase 1 (HDAC1),D04ZDI,N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide,Investigative,CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D05AHZ,6-benzenesulfonylhexanoic acid hydroxamide,Investigative,C1=CC=C(C=C1)S(=O)(=O)CCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D05FEJ,"9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one",Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D05GVY,Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester,Investigative,CC(=O)SCCCCCCC(=O)NC1=CC=CC=C1
HDAC1,Histone deacetylase 1 (HDAC1),D05LLX,4-Butyrylamino-N-hydroxy-benzamide,Investigative,CCCC(=O)NC1=CC=C(C=C1)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D05VFP,7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one,Investigative,C1=CC=C2C=C(C=CC2=C1)OCCCCCCC(=O)C3=NC=CO3
HDAC1,Histone deacetylase 1 (HDAC1),D05XAN,7-Mercapto-heptanoic acid biphenyl-3-ylamide,Investigative,C1=CC=C(C=C1)C2=CC(=CC=C2)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D06IQB,"5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione",Investigative,C1=CC(=CC=C1C2=CC(=S)SS2)O
HDAC1,Histone deacetylase 1 (HDAC1),D06VBN,N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide,Investigative,CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D06XNP,4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide,Investigative,CN(C)C1=CC=C(C=C1)C(=O)NCCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D07FJU,7-Mercapto-heptanoic acid pyridin-3-ylamide,Investigative,C1=CC(=CN=C1)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D09YBN,6-Phenoxy-hexane-1-thiol,Investigative,C1=CC=C(C=C1)OCCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D09ZNU,4-Benzoylamino-N-hydroxy-benzamide,Investigative,C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0A5LS,4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide,Investigative,C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)Cl
HDAC1,Histone deacetylase 1 (HDAC1),D0AX7B,"8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one",Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D0B2ZJ,7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one,Investigative,C1=CC=C(C=C1)C2=CC(=CC=C2)OCCCCCCC(=O)C3=NC=CO3
HDAC1,Histone deacetylase 1 (HDAC1),D0B3ZM,6-Mercapto-hexanoic acid phenylamide,Investigative,C1=CC=C(C=C1)NC(=O)CCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0C0VP,Cyclostellettamine derivative,Investigative,C1CCCCCC[N+]2=CC=CC(=C2)CCCCCCC=CCCCCCC[N+]3=CC=CC(=C3)CCCCC1.C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-]
HDAC1,Histone deacetylase 1 (HDAC1),D0C2KD,N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide,Investigative,C1=CC(=CC=C1C(=O)NCCCCCC(=O)NO)[N+](=O)[O-]
HDAC1,Histone deacetylase 1 (HDAC1),D0D2KE,5-Mercapto-pentanoic acid phenylamide,Investigative,C1=CC=C(C=C1)NC(=O)CCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0E8KR,Octanedioic acid hydroxyamide pyridin-2-ylamide,Investigative,C1=CC=NC(=C1)NC(=O)CCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0F0KS,N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide,Investigative,C1=CC=C(C=C1)NC(=O)C(=O)NCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0H1FZ,2-(methylsulfonylthio)ethyl 2-propylpentanoate,Investigative,CCCC(CCC)C(=O)OCCSS(=O)(=O)C
HDAC1,Histone deacetylase 1 (HDAC1),D0KE3I,(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one,Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)C=CCCCCCC(=O)C3=NC=CO3
HDAC1,Histone deacetylase 1 (HDAC1),D0QO0L,N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide,Investigative,CCC(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0R4BS,N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide,Investigative,
HDAC1,Histone deacetylase 1 (HDAC1),D0R5VG,N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide,Investigative,C1=CC=C(C=C1)CCCCC(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0RU1X,8-Oxo-8-phenyl-octanoic acid,Investigative,C1=CC=C(C=C1)C(=O)CCCCCCC(=O)O
HDAC1,Histone deacetylase 1 (HDAC1),D0S7WQ,N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide,Investigative,C1=CC=C(C=C1)CCCC(=O)NC2=CC=C(C=C2)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0S9JF,6-phenylsulfanylhexanoic acid hydroxamide,Investigative,C1=CC=C(C=C1)SCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0T0SK,ST-2987,Investigative,C1=CC(=CC=C1CON=CC2=CC=C(C=C2)C=CC(=O)NO)[N+](=O)[O-]
HDAC1,Histone deacetylase 1 (HDAC1),D0T4IY,7-Mercapto-heptanoic acid quinolin-3-ylamide,Investigative,C1=CC=C2C(=C1)C=C(C=N2)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0V2ZO,5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide,Investigative,C1=CC(=CC=C1CCCCC(=O)NO)Cl
HDAC1,Histone deacetylase 1 (HDAC1),D0XZ9Q,8-Mercapto-octanoic acid phenylamide,Investigative,C1=CC=C(C=C1)NC(=O)CCCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0YY9M,N-(6-Hydroxycarbamoyl-hexyl)-benzamide,Investigative,C1=CC=C(C=C1)C(=O)NCCCCCCC(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0Z3BM,"7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one",Investigative,C1=CC=C(C=C1)C2=CC=C(C=C2)OCCCCCC(=O)C(F)(F)F
HDAC1,Histone deacetylase 1 (HDAC1),D0Z5KX,7-Mercapto-heptanoic acid benzothiazol-2-ylamide,Investigative,C1=CC=C2C(=C1)N=C(S2)NC(=O)CCCCCCS
HDAC1,Histone deacetylase 1 (HDAC1),D0Z7YS,N-Hydroxy-4-(pentanoylamino-methyl)-benzamide,Investigative,CCCCC(=O)NCC1=CC=C(C=C1)C(=O)NO
HDAC1,Histone deacetylase 1 (HDAC1),D0N0TS,PSAMMAPLIN A,Investigative,C1=CC(=C(C=C1CC(=NO)C(=O)NCCSSCCNC(=O)C(=NO)CC2=CC(=C(C=C2)O)Br)Br)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03FCF,Novolimus,Approved,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0ES1Q,Temsirolimus,Approved,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0K3QS,Everolimus,Approved,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0V7WS,Zotarolimus,Approved,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)N5C=NN=N5)C)C)O)OC)C)C)C)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03LJR,Sirolimus,Approved,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0S5LO,PF-04449913,Approved,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0O3CV,Ridaforolimus,Phase 3,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03DPZ,INK128,Phase 2,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H7XL,OSI-027,Phase 2,COC1=CC=CC2=C1NC(=C2)C3=C4C(=NC=NN4C(=N3)C5CCC(CC5)C(=O)O)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0W3UV,ABI-009,Phase 2,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D00KTV,Salirasib,Phase 2,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D01PGR,SAR245409,Phase 2,CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03NJY,SF1126,Phase 2,C1COCC[N+]1(COC(=O)CCC(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)[O-])C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0D8JB,PF-05212384,Phase 2,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H1WC,LY3023414,Phase 2,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0N5JZ,PF-04691502,Phase 2,CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0O6VZ,GDC-0980/RG7422,Phase 2,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0VG0D,BEZ235,Phase 2,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D00BUO,MM-141,Phase 2,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0TU7B,PQR309,Phase 2,C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0Z2UQ,AZD2014,Phase 2,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D05EXN,CC-223,Phase 1/2,CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0X7IN,BGT226,Phase 1/2,CN1C2=CN=C3C=CC(=CC3=C2N(C1=O)C4=CC(=C(C=C4)N5CCNCC5)C(F)(F)F)C6=CN=C(C=C6)OC
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03IXK,ME-344,Phase 1/2,CC1=C(C=CC2=C1OCC(C2C3=CC=C(C=C3)O)C4=CC=C(C=C4)O)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D08PSC,BI 860585,Phase 1,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0QN5M,LAM-001,Phase 1,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0R9VX,DS-3078,Phase 1,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0U8QH,GDC-0349,Phase 1,CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D1RLY2,CERC 006,Phase 1,COC1=CC=CC2=C1NC(=C2)C3=C4C(=NC=NN4C(=N3)C5CCC(CC5)C(=O)O)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0X4RT,DS-7423,Phase 1,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0Y0FE,PWT-33597,Phase 1,CN(C)CCS(=O)(=O)NC1=CC=C(C=C1)C2=NC(=NC(=N2)N3CCOCC3)N4C5=C(C(=CC=C5)OC)N=C4C(F)F
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0U3DP,VS-5584,Phase 1,CC1=NC2=C(N=C(N=C2N1C(C)C)N3CCOCC3)C4=CN=C(N=C4)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D07TVO,PMID25726713-Compound-49,Patented,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0KH7Q,PMID25726713-Compound-51,Patented,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0WJ3W,PMID25726713-Compound-48,Patented,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0X5VI,PMID25726713-Compound-47,Patented,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0Y8JF,PMID25726713-Compound-50,Patented,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0K1VK,AZD8055,Discontinued in Phase 1/2,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H5MX,TAFA-93,Discontinued in Phase 1,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)OC(=O)CN(C)C)OC)C)C)C)OC.CS(=O)(=O)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D05SXC,SCR-44001,Terminated,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D00GQM,(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)CO
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D01AQN,Rapamycin complexed with immunophilin FKBP12,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D02TCF,C-16-(S)-3-methylindolerapamycin,Investigative,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)C5=CC=CC6=C5NC=C6C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03XRZ,PF-05094037,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D05SOW,SX-MTR1,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D07JKB,2-(6-morpholino-9H-purin-2-yl)phenol,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=CC=C4O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D07NFT,P-2281,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D08BTX,X-387,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D09FBN,4-(6-morpholino-9H-purin-2-yl)phenol,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=C(C=C4)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D09VHS,EM-101,Investigative,C1CN(CCN1)C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0A8ES,EC-0845,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0AH8Q,4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC=CS4
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0E1YN,SB-2280,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0F1SI,4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CSC=C4
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H0HR,torin 1,Investigative,CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H4KF,EC-0565,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0J9PK,OXA-01,Investigative,C1CC(CCC1C2=NC(=C3N2C=CN=C3N)C4=CC5=C(N4)C(=CC=C5)Cl)C(=O)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0N9TK,AR-mTOR-26,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0P0UV,2-chloro-N-(6-cyanopyridin-3-yl)propanamide,Investigative,CC(C(=O)NC1=CN=C(C=C1)C#N)Cl
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0TC5H,3-(6-morpholino-9H-purin-2-yl)phenol,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC(=CC=C4)O
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0U8GR,AP-21967,Investigative,CC1CCC2CC(C(=CC=CC=CC(CC(C(C(C(C(=CC(C(CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)O)C)C)O)OC)O)C)C)C)C5=CNC6=C(C=CC=C56)C
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0Y1DR,4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine,Investigative,C1COCCN1C2=NC(=NC3=C2NC=N3)C4=CC5=C(C=C4)C=CN5
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D2B7WM,Torin2,Investigative,C1=CC(=CC(=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CN=C(C=C5)N)C(F)(F)F
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D02ELN,HM-5016699,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D05RSS,PF-03772304,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0H2CM,PP-242,Investigative,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(N3)C=CC(=C4)O)N
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0JD4S,CU-906,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0QE9F,P-6915,Investigative,
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0T0BY,"2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one",Investigative,C1COCCN1C2=CC(=O)N3C=CC4=CC=CC=C4C3=N2
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0X7TB,2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one,Investigative,CC1CN(CCO1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D0W1ST,Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate,Investigative,C1COCCN1C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3
MTOR,Serine/threonine-protein kinase mTOR (mTOR),D03EHM,PP121,Investigative,C1CCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CN=C5C(=C4)C=CN5)N
PIK3CA,PI3-kinase alpha (PIK3CA),D0W7HE,Alpelisib,Approved,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F
PIK3CA,PI3-kinase alpha (PIK3CA),D0S5LD,BAY 80-6946,Approved,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5
PIK3CA,PI3-kinase alpha (PIK3CA),D0UP1Z,GDC-0032,Phase 3,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C
PIK3CA,PI3-kinase alpha (PIK3CA),D01QSO,Buparlisib,Phase 3,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
PIK3CA,PI3-kinase alpha (PIK3CA),D0H1WC,LY3023414,Phase 2,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC
PIK3CA,PI3-kinase alpha (PIK3CA),D0Y2NS,MLN1117,Phase 1/2,C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N
PIK3CA,PI3-kinase alpha (PIK3CA),D05CBJ,PA-799,Phase 1/2,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N
PIK3CA,PI3-kinase alpha (PIK3CA),D01LMM,BLY719,Phase 1,
PIK3CA,PI3-kinase alpha (PIK3CA),D8IJR1,LY3849524,Phase 1,
PIK3CA,PI3-kinase alpha (PIK3CA),DYF2N4,HHCYH33,Phase 1,COC(=O)NC1=NC=C(C(=C1)C(F)(F)F)C2=NN3C=C(C=C3C(=N2)N4CCOCC4)CN5CCN(CC5)S(=O)(=O)C
PIK3CA,PI3-kinase alpha (PIK3CA),D0Y0FE,PWT-33597,Phase 1,CN(C)CCS(=O)(=O)NC1=CC=C(C=C1)C2=NC(=NC(=N2)N3CCOCC3)N4C5=C(C(=CC=C5)OC)N=C4C(F)F
PIK3CA,PI3-kinase alpha (PIK3CA),DOR1I0,ETP-46321,Investigative,CS(=O)(=O)N1CCN(CC1)CC2=CN3C=C(N=C(C3=N2)N4CCOCC4)C5=CN=C(N=C5)N
